|Bid||67.57 x 400|
|Ask||67.58 x 1600|
|Day's Range||66.88 - 67.78|
|52 Week Range||45.44 - 68.18|
|PE Ratio (TTM)||24.54|
|Earnings Date||Aug 3, 2017 - Aug 7, 2017|
|Dividend & Yield||0.60 (0.89%)|
|1y Target Est||68.74|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cognizant Technology Solutions Corp. Here are 5 ETFs with the largest exposure to CTSH-US. Comparing the performance and risk of Cognizant Technology Solutions Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
TEANECK, N.J., June 16, 2017 /PRNewswire/ -- Cognizant (CTSH), as part of its collaboration with TransCelerate BioPharma Inc., a non-profit organization with membership comprised of global biopharmaceutical companies, today announced new Shared Investigator Platform (SIP) capabilities that make it easier for clinical trial researchers to access, share and analyze data. SIP is a multi-tenanted, cloud-based, open architecture collaboration platform to support common research and clinical trial requirements for the biopharmaceutical industry.
Medalist managers picked up Cognizant, Johnson & Johnson, and Antero Resources during the first quarter of 2017.